Workflow
StoneCo(STNE) - 2025 Q3 - Earnings Call Presentation
2025-11-06 22:00
Financial Performance - Adjusted Gross Profit reached R$1.6 billion, with a margin of 45%[17, 33] - Adjusted Net Income increased to R$641 million for continuing operations[13, 33] - Adjusted Basic EPS for consolidated operations was R$2.57 per share, a 31% year-over-year increase[13, 38] - Total Revenue and Income grew by 16.5% year-over-year to R$3.57 billion[17, 27, 33] Business Growth - MSMB Payments Client Base expanded, reaching 126,000[19] - MSMB TPV (Total Payment Volume) increased by 11% year-over-year, reaching R$20 billion[19] - Banking Active Clients reached 9 million[22] - Retail Deposits increased by 32% year-over-year to R$8.8 billion, with average daily Retail Deposits growing by 40%[22] Capital Allocation - R$2.8 billion was distributed to shareholders through buybacks and a 10% distribution yield (LTM)[10] - R$465 million was deployed in share buybacks during 3Q25[28, 29] Credit Portfolio - Credit Portfolio reached R$2.298 billion[24]
Affirm(AFRM) - 2026 Q1 - Earnings Call Presentation
2025-11-06 22:00
FY Q1 2026 Earnings Supplement November 6, 2025 Safe Harbor Statement/Use of Non-GAAP Financial Measures Cautionary Note About Forward-Looking Statements This document contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended, that involve risks and uncertainties. All statements other than statements of historical fact are forward-looking statements, including stat ...
Clarus(CLAR) - 2025 Q3 - Earnings Call Presentation
2025-11-06 22:00
Financial Performance - Q3 2025 revenue increased by 3% year-over-year to $693 million[17] - Adventure revenue increased by 16% year-over-year to $207 million[17] - Outdoor revenue decreased by 1% year-over-year to $487 million[17], but excluding the divested PIEPS business, comparable Outdoor sales were up 1%[18] - Adjusted gross margin was 351%[17], a decrease of 270 basis points year-over-year[17] - Adjusted EBITDA was $28 million[17] - Black Diamond Q3 revenue, gross margin, and adjusted EBITDA increased year-over-year[22] Strategic Focus - The company is positioned for long-term sustainable growth, guided by a strategic roadmap[14] - Black Diamond is focused on simplification and the core business[14] - Adventure is focused on the basics[14] - The company has a strong balance sheet with $295 million in cash as of September 30, 2025[14]
The Joint (JYNT) - 2025 Q3 - Earnings Call Presentation
2025-11-06 22:00
Financial Performance (Q3 2025) - Revenue increased by 6% to $13.4 million compared to $12.7 million in Q3 2024[31] - Consolidated Adjusted EBITDA increased by 36% to $3.3 million compared to $2.4 million in Q3 2024[28, 31] - System-wide sales decreased by (1.5)% in Q3 2025[28] - Comp sales decreased by (2.0)% in Q3 2025[28] Financial Performance (YTD 2025) - Revenue increased by 6% to $39.7 million compared to $37.4 million in YTD 2024[32] - Consolidated Adjusted EBITDA increased by 16% to $9.4 million compared to $8.1 million in YTD 2024[32] Strategic Initiatives - Focused on becoming a pure-play franchisor, actively engaged in negotiations for the balance of the corporate portfolio[12] - Launched 3 pricing pilots to inform enterprise-wide price increase in Q1 2026[21] - Revising 2025 system-wide sales guidance to $530 million - $534 million[36]
BlackLine(BL) - 2025 Q3 - Earnings Call Presentation
2025-11-06 22:00
Investor Presentation Third Quarter 2025 November 6th, 2025 Safe Harbor This presentation contains forward-looking statements. These statements may relate to, but are not limited to, expectations of future operating results or financial performance of BlackLine, Inc. ("BlackLine" or the "Company"), the calculation of certain key financial and operating metrics, capital expenditures, introduction of new solutions or products, expansion into new markets, plans for growth and future operations, technological c ...
AEYE(LIDR) - 2025 Q3 - Earnings Call Presentation
2025-11-06 22:00
Financial Performance - GAAP净亏损为930万美元[27],与上一季度持平 - Non-GAAP净亏损为540万美元[27],低于上一季度的670万美元[27] - 每股GAAP亏损为030美元[27],低于上一季度的048美元[27] - 每股Non-GAAP亏损为017美元[27],低于上一季度的035美元[27] - 经营活动使用的净现金为610万美元[27],略低于上一季度的640万美元[27] - 现金、现金等价物和有价证券增加4倍至8430万美元[18, 27] Business Highlights - 客户群自第二季度末以来翻了一番,使客户合同总数达到12个[14] - 与Black Sesame、Blue-Band和Flasheye建立了新的合作伙伴关系,以推进自动驾驶和智慧城市智能[16] - 扩大了Apollo的生产能力,达到每年60000台[18] - 开始向全球国防承包商运送用于载人和无人驾驶飞行器的Apollo产品[18] Financial Outlook - 重申2025财年现金消耗指导值为2700万美元至2900万美元[29],反映了扩大Apollo生产和支持商业扩张的计划投资 - 该公司拥有执行战略计划所需的充足增长资本[30] - 该公司在财务约束和运营投资之间取得平衡[30] - 与同行相比,该公司具有有利的成本结构,同行成本结构比AEye高出约85倍[23]
Synaptics(SYNA) - 2026 Q1 - Earnings Call Presentation
2025-11-06 22:00
Financial Performance - Q1 2026 revenue reached $292.5 million, a 14% year-over-year increase[5] - Core IoT revenue experienced substantial growth, increasing by 74% year-over-year[5,6] - Non-GAAP EPS grew by 35% year-over-year, reaching $1.09[5,18] - Non-GAAP gross margin was 53.2%[6,16] - Cash flow from operations amounted to $30 million[16] Revenue Breakdown - Q1 2026 revenue distribution: Mobile contributed $41 million, Core IoT $104 million, and Enterprise & Auto $148 million[15] - Core IoT revenue accounted for 35% of the total revenue in Q1 2026[23] Q2 2026 Guidance (Non-GAAP) - Revenue is projected to be $300 million, with a variance of ± $10 million[31] - Gross margin is expected to be 53.5%, with a variance of ± 1.0%[31] - Operating expenses are estimated at $106 million, with a variance of ± $2 million[31] - EPS is forecasted to be $1.15, with a variance of ± $0.15[31] - Revenue mix forecast: Core IoT 31%, Enterprise & Auto 53%, and Mobile 16%[31]
Elutia(ELUT) - 2025 Q3 - Earnings Call Presentation
2025-11-06 22:00
Business Overview - Elutia sold its BioEnvelope business to Boston Scientific for $88 million [11, 59] - The BioEnvelope business financials are now reported as "Discontinued Operations" [60] - Elutia is targeting the $1.5 billion breast reconstruction market with its technology platform [14, 17, 18, 70] Market Opportunity - Biologics represent 65% of the $1.5 billion US breast reconstruction market [18, 19, 20] - Biologic mesh is used in over 90% of breast reconstruction cases [20] - 15-20% of breast reconstruction patients experience infection [17, 22] - The average economic cost to the hospital of breast reconstruction infection is $48,344 [23] Financial Performance - Q3 2025 net sales were $3.3 million compared to $3.6 million in Q3 2024 [68] - Q3 2025 GAAP gross margin was 55.8% compared to 48.9% in Q3 2024 [68] - Q3 2025 adjusted gross margin was 63.9% compared to 56.3% in Q3 2024 [68] - The company received $49 million in cash at closing from the BioEnvelope sale, net of expenses and debt repayment [68] - The estimated liability of the remaining 6 FiberCel litigation cases is $0.7 million [68]
AbCellera Biologics(ABCL) - 2025 Q3 - Earnings Call Presentation
2025-11-06 22:00
Q3 2025 BUSINESS UPDATE November 6, 2025 COPYRIGHT © ABCELLERA DISCLAIMER This presentation contains forward-looking statements, including statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements are based on management's beliefs and assumptions and on information currently available to management. All statements contained in this presentation other than statements of historical fact are forward-looking statements, includi ...
Progyny(PGNY) - 2025 Q3 - Earnings Call Presentation
2025-11-06 21:45
Financial Performance - Q3 2025 - Revenue increased by 93% compared to Q3 2024, and excluding the impact of a large, former client, revenue grew by 23%[6, 8] - Gross profit increased by 23% compared to Q3 2024, resulting in a gross margin of 232%, a 250 basis point increase year-over-year[6, 8] - Adjusted EBITDA increased by 18% compared to Q3 2024, yielding a 175% Adjusted EBITDA margin, a 130 basis point increase year-over-year[6, 8] - Operating cash flow generated in Q3 2025 was $507 million[6, 8] Financial Performance - Year-to-Date 2025 - Revenue increased by 12% compared to YTD 2024, and excluding the impact of a large, former client, revenue grew by 20%[6, 10] - Gross profit increased by 20% compared to YTD 2024, resulting in a gross margin of 235%, a 160 basis point increase year-over-year[6, 10] - Adjusted EBITDA increased by 13% compared to YTD 2024, yielding a 176% Adjusted EBITDA margin, a 20 basis point increase year-over-year[6, 10] - Operating cash flow generated YTD 2025 was $1560 million, compared to $1269 million in the prior year period[6, 10] Business Highlights - The 2025 selling season produced over 80 new clients and approximately 900000 new covered lives[6] - The company achieved near 100% retention of existing clients, with no large client loss[6] - Nearly 30% of existing clients are expanding benefits in some way for 2026[6] - A new share repurchase program was authorized for up to $200 million[6, 18] Member Engagement - Female utilization in 3Q 2025 was 047%, comparable to the prior year period[6, 12]